Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Pharmacy Facelift: How Walgreens and CVS Aim to Boost Profits

by Team Lumida
May 17, 2024
in Markets, News
Reading Time: 4 mins read
A A
0
woman with face mask holding an alcohol bottle

Photo by Anna Tarazevich on Pexels.com

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

  1. Walgreens and CVS are redesigning stores to emphasize health and wellness.
  2. Rising competition and falling margins drive these changes.
  3. Investors should watch for potential improvements in profitability and customer satisfaction.

What Happened?

Walgreens and CVS are drastically revamping their store layouts to focus on health and wellness, aiming to counter sagging performance. Walgreens, for example, is testing a new store design in Aubrey, Texas, where the pharmacy counter is moved to the front, and customers use self-service kiosks.

CVS is integrating its Oak Street Health primary-care centers into some stores. Both chains have seen significant declines in operating margins, with Walgreens’ U.S. pharmacy operating margin dropping to -5% last year. These redesign efforts are part of broader strategies to improve efficiency and customer experience amid fierce competition from Amazon, Dollar General, and Walmart.

Why It Matters?

These changes are crucial as both Walgreens and CVS struggle with falling margins and investor dissatisfaction. Walgreens’ shares have plummeted 77% over the past decade, and CVS’ shares have dropped 26%.

By making pharmacies more customer-friendly and efficient, they aim to attract more customers and boost profitability. These efforts are essential for long-term sustainability, especially given the increasing role of pharmacists in healthcare services, such as vaccinations and testing.

What’s Next?

Investors should monitor the success of these pilot stores and any subsequent rollouts. If these new designs prove effective, we could see a broader implementation, potentially improving the financial outlook for both companies.

Additionally, keep an eye on the labor situation; reducing pharmacists’ workloads could enhance service quality and customer satisfaction. The success of these initiatives could also pressure competitors to innovate, potentially reshaping the entire pharmacy landscape.

Source: Bloomberg
Previous Post

Medicare Shakeup: Policy Changes Rattle Big Insurers

Next Post

Revolutionizing AI: How DePIN is Solving Robots’ Biggest Blind Spot

Recommended For You

Wall Street Majors Cut Oil Forecasts on Deal to Reopen Hormuz

by Team Lumida
37 minutes ago
Iran’s Island Fortress: The Five Strategic Positions Holding Hormuz Hostage

Goldman Sachs and Morgan Stanley slashed their oil price forecasts after the US-Iran interim deal, with Goldman expecting Brent at $80/barrel in Q4 and Persian Gulf exports back...

Read more

Blood Tests Can Now Detect Alzheimer’s. Should You Get One?

by Team Lumida
44 minutes ago
person in white long sleeve shirt sitting on chair

Two FDA-cleared blood tests can now detect Alzheimer's markers, but neurologists caution they aren't designed for healthy people — and without approved preventive treatments, positive results create anxiety...

Read more

GM in Talks to Supply Weapons Parts to Lockheed Martin

by Team Lumida
46 minutes ago
gray airplane

General Motors is in discussions with Lockheed Martin to manufacture components for the defense contractor's weapons systems, as the Trump administration presses automakers to help replenish US munitions...

Read more

Chinese Economy Stalls as Spending, Investment Drop to Covid-Era Levels

by Team Lumida
48 minutes ago
China’s Bold Economic Moves: What You Need to Know Now

China's retail sales fell 0.6% year-on-year in May — the first decline since Covid lockdowns ended — while fixed-asset investment shrank 4.1%, exposing a deepening split between booming...

Read more

Polymarket Traders Clash Over $345 Million Iran Peace Market

by Team Lumida
48 minutes ago
Indonesia Bans Polymarket After Bets on President Prabowo’s Removal Go Viral

Polymarket's $345 million Iran peace contract is in dispute: traders disagree on whether the US-Iran interim deal meets the contract's requirement for an explicit, permanent end to hostilities...

Read more

US and Iran Prepare for Deal Signing With Both Claiming Victory

by Team Lumida
49 minutes ago
Israel Strikes the Caspian: Hitting the Russia–Iran Weapons Smuggling Pipeline at Its Source

The US and Iran are set to formally sign a 14-point interim peace MOU in Geneva on Friday, with JD Vance leading the American delegation — but disputes...

Read more

SpaceX Stock Set for More Than 50% Jump in Just Three Sessions

by Team Lumida
49 minutes ago
SpaceX’s IPO Is So Big It’s Forcing Wall Street to Rewrite Its Own Rules

SpaceX shares surged another 11% in premarket Tuesday, putting the stock on track for a 50%+ gain across its first three trading sessions — lifting its market cap...

Read more

Kevin Warsh Wants the Fed to Stop Explaining Everything

by Team Lumida
20 hours ago
September Rate Cut Likely as Job Market Risks Increase, Says Fed

New Federal Reserve Chairman Kevin Warsh is preparing to dramatically scale back Fed communications — fewer speeches, a possible end to the dot plot, and shorter press conferences...

Read more

Israel Is Alarmed by Trump’s Deal With Iran

by Team Lumida
20 hours ago
Why Iran Thinks It Won the War — Despite Catastrophic Military Losses

Netanyahu is urgently seeking a meeting with Trump after an Israeli strike on Beirut nearly derailed the US-Iran agreement, and Israel worries Iran will pocket financial relief without...

Read more

SpaceX and OpenAI Are Ending Wall Street’s Era of Stock Scarcity

by Team Lumida
20 hours ago
SpaceX’s IPO Is So Big It’s Forcing Wall Street to Rewrite Its Own Rules

A wave of mega-IPOs from SpaceX, OpenAI, and Anthropic — plus a record Alphabet share sale — is projected to flood markets with $1.5 trillion in new equity...

Read more
Next Post

Revolutionizing AI: How DePIN is Solving Robots’ Biggest Blind Spot

NFT Nightmare: Dolce & Gabbana Sued Over NFT Misstep

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

woman using MacBook Pro with person in white top

Generative A.I. Goldmine: Consultants Rake in Billions as Businesses Seek Guidance

June 27, 2024
Trump Says Coca-Cola Will Switch to Cane Sugar in U.S. Coke After Administration Pressure

Trump Says Coca-Cola Will Switch to Cane Sugar in U.S. Coke After Administration Pressure

July 17, 2025
Supreme Court Signals It Will Strike Down Trump’s Birthright Citizenship Order

Two-Thirds of Americans Are Cutting Back Spending as Iran War Inflation Bites

May 27, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018